Skip to main content

Table 6 Survey results regarding notification and use of MSIS data for Legionnaires’ disease, Norway, 2018

From: Evaluation of the national surveillance of Legionnaires' disease in Norway, 2008-2017

Notification

Answer categories

n

%

95% CI

Upon suspicion of LD, an immediate report to the MMD or NIPH should be done immediately. Do you have a routine for who does this and how?

Yes

31

66

51;79

No

10

21

11;36

Don’t know

6

13

5;26

What is your routine (n = 37)

We report to the MMD where the patient lives

9

24

12;41

We report to NIPH directly and do not contact the MMD

0

0

0;9

We report to both the MMD and NIPH

13

35

20;53

We notify to MSIS

4

11

3;25

Don’t know

5

14

5;29

Other (free text)

6

16

6;32

Do you find it easy to report the MMD or NIPH about a new case of LD?

Yes

23

49

34;64

No

3

6

1;18

Don’t know

21

45

30;60

Who notifies cases of LD to MSIS (submits the form)? Choose all that apply.

The responsible doctor

41

87

74;95

The laboratory

18

38

25;54

Don’t know

2

4

1;15

Other (free text)

5

11

4;23

NIPH has published MSIS notification criteria for LD. Do you find these criteria clear?

Yes

31

66

51;79

No

0

  

Don’t know

16

34

21;49

Use of MSIS data

Do you find LD incidence data from MSIS useful?

Yes

39

83

69;92

No

1

2

0;11

Don’t know

7

15

6;28

Do you find LD incidence data from MSIS easy to access?

Yes

24

51

31;66

No

7

15

6;28

Don’t know

16

34

21;49

Which sources of data do you use to find incidence of LD? Choose all that apply

NIPH Infection Control Guidelines

12

26

14;40

www.MSIS.no

24

51

36;66

Annual reports from NIPH

6

13

5;26

Don’t know

8

17

8;31

Other, please specify (free text)

6

13

5;26

  1. Answers (n = 47) regarding notification and immediate reporting upon suspicion of Legionnaires’ disease (LD) and use of MSIS data from a survey to doctors at Norwegian hospitals that had notified at least one case with LD in the period 2013 to 2017